利好突袭！医药巨头暴涨

Market Performance - The US stock market showed mixed results on November 11, with the Dow Jones Industrial Average reaching a new closing high, up 1.18% to 47,927.96 points, while the S&P 500 rose 0.21% to 6,846.61 points, and the Nasdaq index fell 0.25% to 23,468.3 points [2][4] - Major technology stocks had mixed performances, with Apple rising over 2%, while Nvidia fell nearly 3% and Tesla dropped over 1% [4] Chinese Concept Stocks - The Nasdaq Golden Dragon China Index decreased by 0.06%, with mixed performances among Chinese concept stocks [7] - Xpeng Motors saw a significant increase, with its US stock rising nearly 8% and a cumulative increase of over 20% in the last two trading days, driven by interest in its new humanoid robot, IRON [7][9] Energy Sector - The energy sector experienced collective gains, with ConocoPhillips rising nearly 3% and ExxonMobil increasing over 1% [5] Semiconductor Sector - The semiconductor sector faced declines, with the Philadelphia Semiconductor Index dropping 2.48%, and several companies like Micron Technology and Lam Research seeing declines of over 4% [6] Clinical Trial Results - Novo Nordisk's stock surged nearly 7% following the announcement of positive Phase II clinical trial results for its experimental drug Coramitug, which showed a 48% reduction in NT-proBNP levels at a 60mg/kg dosage [5]